Shinji Ohno

Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients.

Masaru Tomita, Masahiro Sugimoto, Takayuki Ueno, 2010, Journal of medical and dental sciences.

Dose-Finding Phase I and Pharmacokinetic Study of Capecitabine (Xeloda) in Combination with Epirubicin and Cyclophosphamide (CEX) in Patients with Inoperable or Metastatic Breast Cancer

Satoshi Morita, Junichi Sakamoto, Masakazu Toi, 2008, Oncology.

Histological classification of invasive ductal carcinoma and the biological parameters in breast cancer

Shinji Ohno, Shinichi Tsutsui, Shigeru Murakami, 2003, Breast cancer.

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

S. Tsutsui, S. Ohno, S. Oda, 2004, Breast Cancer Research and Treatment.

Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer

Yoshiaki Nakamura, S. Ohno, K. Taguchi, 2014, Breast Cancer.

Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.

S. Tsutsui, S. Ohno, Shinji Ohno, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype

Takuji Iwase, Futoshi Akiyama, F. Akiyama, 2016, SpringerPlus.

Phyllodes tumor of the breast: correlation between MR findings and histologic grade.

Hiroshi Honda, Hidetake Yabuuchi, Kenichi Nishiyama, 2006, Radiology.

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan

Norikazu Masuda, Eriko Tokunaga, T. Shien, 2015, Cancer nursing.